SFA
CMPX icon

Sequoia Financial Advisors’s Compass Therapeutics CMPX Stock Holding History

Sequoia Financial Advisors’s Portfolio CMPX Stock Details CMPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$98.5K Buy
44,980
+29,445
+190% +$86.9K ﹤0.01% 2077
2026
Q1 		$82.2K Sell
15,535
-359
-2% -$2.07K ﹤0.01% 1868
2025
Q4 		$85.4K Buy
15,894
+141
+0.9% +$651 ﹤0.01% 1881
2025
Q3 		$55.1K Sell
15,753
-732
-4% -$2.31K ﹤0.01% 1715
2025
Q2 		$42.9K Sell
16,485
-11,449
-41% -$23.6K ﹤0.01% 1559
2025
Q1 		$53.1K Sell
27,934
-2,942
-10% -$7.82K ﹤0.01% 1347
2024
Q4 		$44.8K Buy
+30,876
New +$51.3K ﹤0.01% 1315

Other funds holding CMPX

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Sequoia Financial Advisors's CMPX Position: Q2 2026 in Review

Sequoia Financial Advisors increased its Compass Therapeutics (CMPX) stake by 190% in Q2 2026, buying an estimated $86.9K and bringing the position to 44,980 shares worth $98.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2077.

Sequoia Financial Advisors first reported a position in CMPX in Q4 2024 and has held it in 7 quarters since. 215 funds tracked by Wall St. Rank hold CMPX as of Q2 2026.

  • Sequoia Financial Advisors held 44,980 shares of Compass Therapeutics worth $98.5K as of Q2 2026.
  • Sequoia Financial Advisors bought 29,445 Compass Therapeutics shares in Q2 2026, an estimated $86.9K.
  • Compass Therapeutics made up ﹤0.01% of Sequoia Financial Advisors's portfolio in Q2 2026, its #2077 holding.
  • Sequoia Financial Advisors first reported a position in Compass Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • 215 funds tracked by Wall St. Rank held Compass Therapeutics as of Q2 2026.

Based on Sequoia Financial Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.